Treatment of peritoneal metastases from gastric carcinoma
Patients with advanced gastric cancer and positive peritoneal cytology and/or peritoneal dissemination are deemed to be incurable and to hold dismal prognosis. So far, the only treatment option for these patients has been palliative systemic (chemo)therapy. However, for the last three decades, great...
Glavni autori: | Polkowski Wojciech P., Rawicz-Pruszynski Karol, Mielko Jerzy, Geca Katarzyna, Skorzewska Magdalena, Cisel Bogumila |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Sciendo
2017-12-01
|
Serija: | Current Issues in Pharmacy and Medical Sciences |
Teme: | |
Online pristup: | https://doi.org/10.1515/cipms-2017-0032 |
Slični predmeti
-
Advances in surgery for peritoneal surface malignancies
od: Mielko Jerzy, i dr.
Izdano: (2017-12-01) -
Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
od: Skierucha Malgorzata, i dr.
Izdano: (2017-12-01) -
Diaphragmatic peritoneal metastases mimicking liver metastases
od: Noiret Barbara, i dr.
Izdano: (2021-08-01) -
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
od: Simkens GA, i dr.
Izdano: (2017-06-01) -
Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
od: Özgül Düzgün, i dr.
Izdano: (2019-09-01)